Z-1188-2024 Class III Ongoing

Recalled by Abbott Molecular, Inc. — Des Plaines, IL

FDA device recall Z-1188-2024 was initiated by Abbott Molecular, Inc. on Feb 1, 2024 and is designated Class III. Reason for recall: Products that were intended for export only which were not approved or registered in accordance with U.S. specifications were shipped to U.S. customers. The recall status is ongoing. Affected quantity: 16 kits.

Recall details

Product Type
Devices
Report Date
Mar 6, 2024
Initiation Date
Feb 1, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16 kits

Product description

In-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit, REF 01N15-010; (2) Abbott Vysis LSI D13S319 (13q14.3) SpectrumOrange Probe, REF 01N34-020;

Reason for recall

Products that were intended for export only which were not approved or registered in accordance with U.S. specifications were shipped to U.S. customers.

Distribution pattern

US Nationwide distribution in the states of AL, CA, IL, MA, MD, MN, NY, and PA.

Code information

(1) REF 01N15-010 - GTIN 00884999035362, Lot #381146, Exp. 2024-05-05; #381870, Exp. 2024-05-05; #382179 Exp. 2024-05-05; #387021, Exp. 2024-08-01; #528081, exp. 2023-11-16; (2) REF 01N34-020 - GTIN 00884999000766, Lot #522756, Exp. 2023-06-21.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1188-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1188-2024. Report a data issue: hello@regdatalab.com.